Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects.

Filippo O, D'Ascenzo F, Raposeiras-Roubin S, Abu-Assi E, Peyracchia M, Bocchino PP, Kinnaird T, Ariza-Solé A, Liebetrau C, Manzano-Fernández S, Boccuzzi G, Henriques JPS, Templin C, Wilton SB, Omedè P, Velicki L, Xanthopoulou I, Correia L, Cerrato E, Rognoni A, Fabrizio U, Nuñez-Gil I, Iannaccone M, Montabone A, Taha S, Fujii T, Durante A, Song X, Gili S, Magnani G, Varbella F, Kawaji T, Blanco PF, Garay A, Quadri G, Alexopoulos D, Queija BC, Huczek Z, Paz RC, González Juanatey JR, Fernández MC, Nie SP, Pousa IM, Kawashiri MA, Gallo D, Morbiducci U, Conrotto F, Montefusco A, Dominguez-Rodriguez A, López-Cuenca A, Cequier A, Iñiguez-Romo A, Usmiani T, Rinaldi M, De Ferrari GM.

Eur Heart J Cardiovasc Pharmacother. 2019 Sep 12. pii: pvz048. doi: 10.1093/ehjcvp/pvz048. [Epub ahead of print]

PMID:
31511896
2.

Same-Day Discharge After Elective Percutaneous Coronary Intervention: Insights From the British Cardiovascular Intervention Society.

Taxiarchi P, Kontopantelis E, Martin GP, Kinnaird T, Curzen N, Banning AP, Ludman P, De Belder M, Rashid M, Sperrin M, Mamas MA.

JACC Cardiovasc Interv. 2019 Aug 12;12(15):1479-1494. doi: 10.1016/j.jcin.2019.03.030.

PMID:
31395218
3.

Coronary perforation complicating percutaneous coronary intervention in patients presenting with an acute coronary syndrome: An analysis of 1013 perforation cases from the British Cardiovascular Intervention Society database.

Kinnaird T, Kwok CS, Davies R, Calvert PA, Anderson R, Gallagher S, Sirker A, Ludman P, deBelder M, Stables R, Johnson TW, Kontopantelis E, Curzen N, Mamas M; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

Int J Cardiol. 2019 Jun 14. pii: S0167-5273(18)36651-8. doi: 10.1016/j.ijcard.2019.06.034. [Epub ahead of print]

PMID:
31253528
4.

Treatment of patients with diffuse coronary disease: a challenge yet to be solved?

Kinnaird T, Mamas MA.

Pol Arch Intern Med. 2019 Jun 28;129(6):365-366. doi: 10.20452/pamw.14883. Epub 2019 Jun 28. No abstract available.

5.

Comparison of Routine Versus Selective Glycoprotein IIb/IIIa Inhibitors Usage in Primary Percutaneous Coronary Intervention (from the British Cardiovascular Interventional Society).

Orzalkiewicz M, Hodson J, Kwok CS, Ludman PF, Giblett JP, George S, Doshi SN, Khan SQ, Kinnaird T, Hildick-Smith D, Townend JN, Mamas MA, Calvert PA.

Am J Cardiol. 2019 Aug 1;124(3):373-380. doi: 10.1016/j.amjcard.2019.05.010. Epub 2019 May 9.

PMID:
31146891
6.

Combinations of bleeding and ischemic risk and their association with clinical outcomes in acute coronary syndrome.

Mohamed MO, Kinnaird T, Anderson R, Rashid M, Martin GP, Freeman P, Kwok CS, Myint PK, Zaman AG, Mamas MA.

Int J Cardiol. 2019 Sep 1;290:7-14. doi: 10.1016/j.ijcard.2019.05.035. Epub 2019 May 21.

PMID:
31133430
7.

Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry.

De Fillippo O, Cortese M, D Ascenzo F, Raposeiras-Roubin S, Abu-Assi E, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Montefusco A, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Blanco PF, Garay A, Quadri G, Varbella F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Rinaldi M.

Am J Cardiovasc Drugs. 2019 Aug;19(4):429. doi: 10.1007/s40256-019-00351-7.

PMID:
31106384
8.

Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry.

De Filippo O, Cortese M, D Ascenzo F, Raposeiras-Roubin S, Abu-Assi E, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Montefusco A, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Blanco PF, Garay A, Quadri G, Varbella F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Rinaldi M.

Am J Cardiovasc Drugs. 2019 Aug;19(4):381-391. doi: 10.1007/s40256-019-00339-3. Erratum in: Am J Cardiovasc Drugs. 2019 May 20;:.

PMID:
31030413
9.

In-hospital gastrointestinal bleeding following percutaneous coronary intervention.

Kwok CS, Sirker A, Farmer AD, Kontopantelis E, Potts J, Ayyaz Ul Haq M, Ludman P, de Belder M, Townend J, Zaman A, Large A, Kinnaird T, Mamas MA; British Cardiovascular Intervention Society (BCIS) and National Institute of Cardiovascular Outcomes Research (NICOR).

Catheter Cardiovasc Interv. 2019 Apr 8. doi: 10.1002/ccd.28222. [Epub ahead of print]

PMID:
30963681
10.

Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission Database.

Kwok CS, Shah B, Al-Suwaidi J, Fischman DL, Holmvang L, Alraies C, Bagur R, Nagaraja V, Rashid M, Mohamed M, Martin GP, Kontopantelis E, Kinnaird T, Mamas M.

JACC Cardiovasc Interv. 2019 Apr 22;12(8):734-748. doi: 10.1016/j.jcin.2019.02.007. Epub 2019 Mar 27.

PMID:
30928446
11.

Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.

D'Ascenzo F, Bertaina M, Fioravanti F, Bongiovanni F, Raposeiras-Roubin S, Abu-Assi E, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Blanco PF, Garay A, Quadri G, Varbella F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Rinaldi M, Lüscher TF.

Eur J Prev Cardiol. 2019 Mar 12:2047487319836327. doi: 10.1177/2047487319836327. [Epub ahead of print]

PMID:
30862233
12.

Incidence and prognostic impact of post discharge bleeding post acute coronary syndrome within an outpatient setting: a systematic review.

Ismail N, Jordan KP, Rao S, Kinnaird T, Potts J, Kadam UT, Mamas MA.

BMJ Open. 2019 Feb 20;9(2):e023337. doi: 10.1136/bmjopen-2018-023337.

13.

Temporal trends and predictors of time to coronary angiography following non-ST-elevation acute coronary syndrome in the USA.

Rashid M, Fischman DL, Martinez SC, Capers Q 4th, Savage M, Zaman A, Curzen N, Ensor J, Potts J, Mohamed MO, Kwok CS, Kinnaird T, Bagur R, Mamas M.

Coron Artery Dis. 2019 May;30(3):159-170. doi: 10.1097/MCA.0000000000000693.

PMID:
30676387
14.

"No Such Thing as a Free Lunch": Personalized P2Y12 Inhibition to Optimize Patient Outcomes.

Kinnaird T.

J Am Heart Assoc. 2019 Jan 22;8(2):e011660. doi: 10.1161/JAHA.118.011660.

15.

Access Site and Outcomes for Unprotected Left Main Stem Percutaneous Coronary Intervention: An Analysis of the British Cardiovascular Intervention Society Database.

Kinnaird T, Anderson R, Gallagher S, Sirker A, Ludman P, de Belder M, Copt S, Oldroyd K, Curzen N, Banning A, Mamas M.

JACC Cardiovasc Interv. 2018 Dec 24;11(24):2480-2491. doi: 10.1016/j.jcin.2018.09.035.

PMID:
30573059
16.

Outcomes Following Percutaneous Coronary Intervention in Non-ST-Segment-Elevation Myocardial Infarction Patients With Coronary Artery Bypass Grafts.

Shoaib A, Kinnaird T, Curzen N, Kontopantelis E, Ludman P, de Belder M, Rashid M, Kwok CS, Nolan J, Zaman A, Mamas MA.

Circ Cardiovasc Interv. 2018 Nov;11(11):e006824. doi: 10.1161/CIRCINTERVENTIONS.118.006824.

PMID:
30571201
17.

Procedural Success and Outcomes With Increasing Use of Enabling Strategies for Chronic Total Occlusion Intervention.

Kinnaird T, Gallagher S, Cockburn J, Sirker A, Ludman P, de Belder M, Smith E, Anderson R, Strange J, Mamas M, Hildick-Smith D; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

Circ Cardiovasc Interv. 2018 Oct;11(10):e006436. doi: 10.1161/CIRCINTERVENTIONS.118.006436.

PMID:
30354634
18.

Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI.

Conrotto F, Bertaina M, Raposeiras-Roubin S, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Quadri G, Varbella F, Caneiro Queija B, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Abu-Assi E, D'Ascenzo F.

Eur Heart J Acute Cardiovasc Care. 2018 Oct 1:2048872618802783. doi: 10.1177/2048872618802783. [Epub ahead of print]

PMID:
30270638
19.

Twelve-month outcomes of patients unsuitable for prolonged DAPT presenting with an acute coronary syndrome and treated with polymer-free biolimus A9 drug-coated stents.

Kinnaird T, Abdul F, Hailan A, Sheikh A, Hinton J, Yazji K, Elangovan S, Yousef A, Gallagher S, Choudhury A, Anderson R, O'Kane P, Smith D.

Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1220-1228. doi: 10.1002/ccd.27722. Epub 2018 Sep 23.

PMID:
30244504
20.

Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry.

D'Ascenzo F, Grosso A, Abu-Assi E, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Ali HH, Magnani G, Autelli M, Blanco PF, Garay A, Quadri G, Marra WG, Varbella F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Raposeiras-Roubin S.

Int J Cardiol. 2018 Dec 15;273:29-33. doi: 10.1016/j.ijcard.2018.09.020. Epub 2018 Sep 6.

PMID:
30228021
21.

Changes in Periprocedural Bleeding Complications Following Percutaneous Coronary Intervention in The United Kingdom Between 2006 and 2013 (from the British Cardiovascular Interventional Society).

Olier I, Carr M, Curzen N, Ludman P, Baumbach A, Kinnaird T, de Belder MA, Hildick-Smith D, Sirker A, Kwok CS, Rashid M, Nolan J, Kontopantelis E, Mamas MA.

Am J Cardiol. 2018 Sep 15;122(6):952-960. doi: 10.1016/j.amjcard.2018.06.016. Epub 2018 Jul 8.

PMID:
30131105
22.

Temporal Changes in Co-Morbidity Burden in Patients Having Percutaneous Coronary Intervention and Impact on Prognosis.

Potts J, Kwok CS, Ensor J, Rashid M, Kadam U, Kinnaird T, Curzen N, Pancholy SB, Van der Windt D, Riley RD, Bagur R, Mamas MA.

Am J Cardiol. 2018 Sep 1;122(5):712-722. doi: 10.1016/j.amjcard.2018.05.003. Epub 2018 Jun 19.

PMID:
30072123
23.

Association of comorbid burden with clinical outcomes after transcatheter aortic valve implantation.

Bagur R, Martin GP, Nombela-Franco L, Doshi SN, George S, Toggweiler S, Sponga S, Cotton JM, Khogali SS, Ratib K, Kinnaird T, Anderson RA, Chu MWA, Kiaii B, Biagioni C, Schofield-Kelly L, Loretz L, Torracchi L, Sekar B, Kwok CS, Sperrin M, Ludman PF, Mamas MA.

Heart. 2018 Dec;104(24):2058-2066. doi: 10.1136/heartjnl-2018-313356. Epub 2018 Jul 20.

PMID:
30030336
24.

Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome.

Raposeiras-Roubín S, Caneiro Queija B, D'Ascenzo F, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Quadri G, Rognoni A, Boccuzzi G, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Varbella F, Tomassini F, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Domínguez-Rodríguez A, Baz-Alonso JA, Calvo-Iglesias F, Valdés M, Cequier Á, Gaita F, Alexopoulos D, Íñiguez-Romo A, Abu-Assi E.

Rev Esp Cardiol (Engl Ed). 2019 Mar;72(3):215-223. doi: 10.1016/j.rec.2018.06.004. Epub 2018 Jul 18. English, Spanish.

PMID:
30029980
25.

Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel.

Raposeiras-Roubín S, Abu-Assi E, D'Ascenzo F, Fernández-Barbeira S, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Quadri G, Rognoni A, Boccuzzi G, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Varbella F, Tommassini F, Caneiro Queija B, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Domínguez-Rodríguez A, Baz-Alonso JA, Valdés M, Cequier Á, Gaita F, Alexopoulos D, Íñiguez-Romo A.

Rev Esp Cardiol (Engl Ed). 2019 Apr;72(4):298-304. doi: 10.1016/j.rec.2018.05.021. Epub 2018 Jun 25. English, Spanish.

PMID:
29954720
26.

Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry.

Guerrero C, Garay A, Ariza-Solé A, Formiga F, Raposeiras-Roubín S, Abu-Assi E, D'Ascenzo F, Kinnaird T, Manzano-Fernández S, Alegre O, Sánchez-Salado JC, Lorente V, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Conrotto F, Bertaina M, Autelli M, Grosso A, Blanco PF, Quadri G, Varbella F, Tomassini F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Alexopoulos D, Iñiguez-Romo A, Gaita F, Cequier Á.

Thromb Res. 2018 Jul;167:142-148. doi: 10.1016/j.thromres.2018.05.024. Epub 2018 May 22.

PMID:
29857270
27.

Incidence, Determinants, and Outcomes of Left and Right Radial Access Use in Patients Undergoing Percutaneous Coronary Intervention in the United Kingdom: A National Perspective Using the BCIS Dataset.

Rashid M, Lawson C, Potts J, Kontopantelis E, Kwok CS, Bertrand OF, Shoaib A, Ludman P, Kinnaird T, de Belder M, Nolan J, Mamas MA.

JACC Cardiovasc Interv. 2018 Jun 11;11(11):1021-1033. doi: 10.1016/j.jcin.2018.01.252. Epub 2018 May 16.

28.

Health Economic Analysis of Access Site Practice in England During Changes in Practice: Insights From the British Cardiovascular Interventional Society.

Mamas MA, Tosh J, Hulme W, Hoskins N, Bungey G, Ludman P, de Belder M, Kwok CS, Verin N, Kinnaird T, Bennett E, Curzen N, Nolan J, Kontopantelis E.

Circ Cardiovasc Qual Outcomes. 2018 May;11(5):e004482. doi: 10.1161/CIRCOUTCOMES.117.004482.

PMID:
29743163
29.

Temporal changes in radial access use, associates and outcomes in patients undergoing PCI using rotational atherectomy between 2007 and 2014: results from the British Cardiovascular Intervention Society national database.

Kinnaird T, Cockburn J, Gallagher S, Choudhury A, Sirker A, Ludman P, de Belder M, Copt S, Mamas M, de Belder A.

Am Heart J. 2018 Apr;198:46-54. doi: 10.1016/j.ahj.2018.01.001. Epub 2018 Jan 7.

PMID:
29653648
30.

Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost: Insights From the Nationwide Readmission Database.

Kwok CS, Rao SV, Potts JE, Kontopantelis E, Rashid M, Kinnaird T, Curzen N, Nolan J, Bagur R, Mamas MA.

JACC Cardiovasc Interv. 2018 Apr 9;11(7):665-674. doi: 10.1016/j.jcin.2018.01.248.

31.

Operator volume is not associated with mortality following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society registry.

Hulme W, Sperrin M, Curzen N, Kinnaird T, De Belder MA, Ludman P, Kwok CS, Gale CP, Cockburn J, Kontopantelis E, Mamas MA; British Cardiovascular Intervention Society and the National Institute of Cardiovascular Outcomes Research.

Eur Heart J. 2018 May 7;39(18):1623-1634. doi: 10.1093/eurheartj/ehy125.

PMID:
29579219
32.

Vascular Access Site and Outcomes in 58,870 Patients Undergoing Percutaneous Coronary Intervention With a Previous History of Coronary Bypass Surgery: Results From the British Cardiovascular Interventions Society National Database.

Kinnaird T, Anderson R, Gallagher S, Cockburn J, Sirker A, Ludman P, de Belder M, Copt S, Nolan J, Zaman A, Mamas M.

JACC Cardiovasc Interv. 2018 Mar 12;11(5):482-492. doi: 10.1016/j.jcin.2017.12.020.

33.

Weekend effect in acute coronary syndrome: A meta-analysis of observational studies.

Kwok CS, Al-Dokheal M, Aldaham S, Rushton C, Butler R, Kinnaird T, Zaman A, Zaman MJ, Timmis A, Mamas MA.

Eur Heart J Acute Cardiovasc Care. 2019 Aug;8(5):432-442. doi: 10.1177/2048872618762634. Epub 2018 Mar 2.

PMID:
29498538
34.

Retroperitoneal Hemorrhage After Percutaneous Coronary Intervention: Incidence, Determinants, and Outcomes as Recorded by the British Cardiovascular Intervention Society.

Kwok CS, Kontopantelis E, Kinnaird T, Potts J, Rashid M, Shoaib A, Nolan J, Bagur R, de Belder MA, Ludman P, Mamas MA; British Cardiovascular Intervention Society (BCIS) and National Institute of Cardiovascular Outcomes Research (NICOR).

Circ Cardiovasc Interv. 2018 Feb;11(2):e005866. doi: 10.1161/CIRCINTERVENTIONS.117.005866.

PMID:
29445000
35.

Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention.

Olier I, Sirker A, Hildick-Smith DJR, Kinnaird T, Ludman P, de Belder MA, Baumbach A, Byrne J, Rashid M, Curzen N, Mamas MA; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

Heart. 2018 Oct;104(20):1683-1690. doi: 10.1136/heartjnl-2017-312366. Epub 2018 Feb 2.

PMID:
29437885
36.

Impact of Access Site Practice on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Following Thrombolysis for ST-Segment Elevation Myocardial Infarction in the United Kingdom: An Insight From the British Cardiovascular Intervention Society Dataset.

Rashid M, Rushton CA, Kwok CS, Kinnaird T, Kontopantelis E, Olier I, Ludman P, De Belder MA, Nolan J, Mamas MA.

JACC Cardiovasc Interv. 2017 Nov 27;10(22):2258-2265. doi: 10.1016/j.jcin.2017.07.049.

37.

Effect of weekend admission on process of care and clinical outcomes for the management of acute coronary syndromes: a retrospective analysis of three UK centres.

Martin GP, Kinnaird T, Sperrin M, Anderson R, Gamal A, Jabbar A, Kwok CS, Barker D, Heatlie G, Zaman AG, Mamas MA.

BMJ Open. 2017 Sep 29;7(9):e016866. doi: 10.1136/bmjopen-2017-016866.

38.

Coronary Perforation Complicating Percutaneous Coronary Intervention in Patients With a History of Coronary Artery Bypass Surgery: An Analysis of 309 Perforation Cases From the British Cardiovascular Intervention Society Database.

Kinnaird T, Anderson R, Ossei-Gerning N, Cockburn J, Sirker A, Ludman P, de Belder M, Johnson TW, Copt S, Zaman A, Mamas MA; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

Circ Cardiovasc Interv. 2017 Sep;10(9). pii: e005581. doi: 10.1161/CIRCINTERVENTIONS.117.005581.

PMID:
28916604
39.

Baseline anemia in patients undergoing percutaneous coronary intervention after an acute coronary syndrome-A paradox of high bleeding risk, high ischemic risk, and complex coronary disease.

Yazji K, Abdul F, Elangovan S, Ul Haq MZ, Ossei-Gerning N, Morris K, Anderson R, Kinnaird T.

J Interv Cardiol. 2017 Oct;30(5):491-499. doi: 10.1111/joic.12406. Epub 2017 Jul 13.

PMID:
28707308
40.

Legacy Effect of Coronary Perforation Complicating Percutaneous Coronary Intervention for Chronic Total Occlusive Disease: An Analysis of 26 807 Cases From the British Cardiovascular Intervention Society Database.

Kinnaird T, Anderson R, Ossei-Gerning N, Cockburn J, Sirker A, Ludman P, deBelder M, Walsh S, Smith E, Hanratty C, Spratt J, Strange J, Hildick-Smith D, Mamas MA; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

Circ Cardiovasc Interv. 2017 May;10(5). pii: e004642. doi: 10.1161/CIRCINTERVENTIONS.116.004642.

PMID:
28500138
41.

Choice of Stent for Percutaneous Coronary Intervention of Saphenous Vein Grafts.

Iqbal J, Kwok CS, Kontopantelis E, de Belder MA, Ludman PF, Large A, Butler R, Gamal A, Kinnaird T, Zaman A, Mamas MA; British Cardiovascular Intervention Society (BCIS) and National Institute of Cardiovascular Outcome Research (NICOR).

Circ Cardiovasc Interv. 2017 Apr;10(4). pii: e004457. doi: 10.1161/CIRCINTERVENTIONS.116.004457.

PMID:
28404622
42.

Vascular Access Site and Outcomes Among 26,807 Chronic Total Coronary Occlusion Angioplasty Cases From the British Cardiovascular Interventions Society National Database.

Kinnaird T, Anderson R, Ossei-Gerning N, Gallagher S, Large A, Strange J, Ludman P, de Belder M, Nolan J, Hildick-Smith D, Mamas M.

JACC Cardiovasc Interv. 2017 Apr 10;10(7):635-644. doi: 10.1016/j.jcin.2016.11.055.

43.

Increased Radial Access Is Not Associated With Worse Femoral Outcomes for Percutaneous Coronary Intervention in the United Kingdom.

Hulme W, Sperrin M, Kontopantelis E, Ratib K, Ludman P, Sirker A, Kinnaird T, Curzen N, Kwok CS, De Belder M, Nolan J, Mamas MA; British Cardiovascular Intervention Society and the National Institute of Cardiovascular Outcomes Research.

Circ Cardiovasc Interv. 2017 Feb;10(2):e004279. doi: 10.1161/CIRCINTERVENTIONS.116.004279.

PMID:
28196898
44.

Cancer Event Rate and Mortality with Thienopyridines: A Systematic Review and Meta-Analysis.

Kotronias RA, Kwok CS, Wong CW, Kinnaird T, Zaman A, Mamas MA.

Drug Saf. 2017 Mar;40(3):229-240. doi: 10.1007/s40264-016-0481-2. Review.

PMID:
28035491
45.

Management of immune thrombocytic purpura and acute coronary syndrome: A double-edged sword!

Shah AH, Anderson RA, Khan AR, Kinnaird TD.

Hellenic J Cardiol. 2016 Aug 20. pii: S1109-9666(16)30151-8. doi: 10.1016/j.hjc.2014.10.001. [Epub ahead of print]

46.

Comparison of the Effects of Incomplete Revascularization on 12-Month Mortality in Patients <80 Compared With ≥80 Years Who Underwent Percutaneous Coronary Intervention.

Yazji K, Abdul F, Elangovan S, Ossei-Gerning N, Choudhury A, Cockburn J, Anderson R, Mamas M, Kinnaird T.

Am J Cardiol. 2016 Oct 15;118(8):1164-1170. doi: 10.1016/j.amjcard.2016.07.031. Epub 2016 Jul 29.

PMID:
27553100
47.

Meta-Analysis of Percutaneous Coronary Intervention With Drug-Eluting Stent Versus Coronary Artery Bypass Grafting for Isolated Proximal Left Anterior Descending Coronary Disease.

Kinnaird T, Kwok CS, Narain A, Butler R, Ossei-Gerning N, Ludman P, Moat N, Anderson R, Mamas MA.

Am J Cardiol. 2016 Oct 15;118(8):1171-1177. doi: 10.1016/j.amjcard.2016.07.030. Epub 2016 Jul 29.

PMID:
27553097
48.

Incidence, Determinants, and Outcomes of Coronary Perforation During Percutaneous Coronary Intervention in the United Kingdom Between 2006 and 2013: An Analysis of 527 121 Cases From the British Cardiovascular Intervention Society Database.

Kinnaird T, Kwok CS, Kontopantelis E, Ossei-Gerning N, Ludman P, deBelder M, Anderson R, Mamas MA; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

Circ Cardiovasc Interv. 2016 Aug;9(8). pii: e003449. doi: 10.1161/CIRCINTERVENTIONS.115.003449.

PMID:
27486140
49.

Early Clinical Experience with a Polymer-Free Biolimus A9 Drug-Coated Stent in DES-Type Patients Who Are Poor Candidates for Prolonged Dual Anti-Platelet Therapy.

Kinnaird T, Butt M, Abdul F, Yazji K, Hailan A, Gallagher S, Ossei-Gerning N, Chase A, Choudhury A, Smith D, Anderson R.

PLoS One. 2016 Jun 30;11(6):e0157812. doi: 10.1371/journal.pone.0157812. eCollection 2016.

50.

Is There a Relationship of Operator and Center Volume With Access Site-Related Outcomes? An Analysis From the British Cardiovascular Intervention Society.

Hulme W, Sperrin M, Rushton H, Ludman PF, De Belder M, Curzen N, Kinnaird T, Kwok CS, Buchan I, Nolan J, Mamas MA.

Circ Cardiovasc Interv. 2016 May;9(5):e003333. doi: 10.1161/CIRCINTERVENTIONS.115.003333.

PMID:
27162213

Supplemental Content

Loading ...
Support Center